(Q43593913)

English

Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines

scientific article published in June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

A M Bergman

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

B Munch-Petersen

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P B Jensen

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Sehested

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

G Veerman

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

D A Voorn

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

K Smid

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H M Pinedo

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

G J Peters

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1401-1408

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Intratumoral pharmacokinetic analysis by 19F-magnetic resonance spectroscopy and cytostatic in vivo activity of gemcitabine (dFdC) in two small cell lung cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Human T-lymphoblast deoxycytidine kinase: purification and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

P-glycoprotein--a marker of cancer-cell behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Multidrug-resistant gene expression in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Concentration of nucleotides and deoxynucleotides in peripheral and phytohemagglutinin-stimulated mammalian lymphocytes. Effects of adenosine and deoxyadenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2'-deoxyadenosine (Cladribine) in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900627-X

7 January 2021

Identifiers

10.1016/S0006-2952(01)00627-X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43593913&oldid=2101762275"